SECAUCUS, N.J., Sept. 7, 2018 /PRNewswire/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the world's leading provider
of diagnostic information services, announced that it is scheduled
to speak at the Morgan Stanley Global Healthcare Conference in New
York City. Stephen Rusckowski,
Chairman, President and CEO and Mark
Guinan, Executive Vice President and CFO will discuss the
company's vision, goals and two-point strategy to accelerate growth
and drive operational excellence. The presentation is scheduled for
Wednesday, September 12, 2018 at
10:30 a.m. Eastern Time.
The presentation will be webcast live during the conference and
will be available on the company's investor relations page which
can be accessed at ir.QuestDiagnostics.com. In addition, the
archived webcast will be available within 24 hours after the
conclusion of the live event and will remain available until
October 12, 2018.
About Quest Diagnostics
Quest
Diagnostics empowers people to take action to improve health
outcomes. Derived from the world's largest database of
clinical lab results, our diagnostic insights reveal new avenues to
identify and treat disease, inspire healthy behaviors and improve
health care management. Quest annually serves one in three adult
Americans and half the physicians and hospitals
in the United States, and our 45,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform
lives. www.QuestDiagnostics.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-global-healthcare-conference-300708753.html
SOURCE Quest Diagnostics Incorporated